Filing metadata

Accession number
0001209191-23-021202
Form type
Form 4
Filer
Inozyme Pharma, Inc.
CIK
CIK 1693011
Filed
Mar 27, 2023
Reporting period
Mar 23, 2023
Description
Insider transaction

Explore SEC Filings Hub